<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/hgncIdPage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedWaterSolubility> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/reaction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdrhealthLink> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/affectedOrganism> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/target> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggCompoundId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiKey> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genecardId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/goClassificationProcess> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://xmlns.com/foaf/0.1/page> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/specificFunction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbIdPage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogpHydrophobicity> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/targets> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pfamDomainFunctionPage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/hgncId> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/hgncId> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/hgncId> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://dbpedia.org/ontology/hgncidLink> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/hgncId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/proteinBinding> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genatlasId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemCompoundId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/theoreticalPi> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/synonym> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/secondaryAccessionNumber> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugCategory> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/hetId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www.w3.org/2002/07/owl#sameAs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/locus> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugInteractions> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalCaco2Permeability> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/essentiality> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chromosomeLocation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://dbpedia.org/ontology/uniprotLink> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggDrugId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/synthesisReference> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringCanonical> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/ahfsCode> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankIdGenePage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringIsomeric> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/biotransformation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www.w3.org/2000/01/rdf-schema#label> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dosageForm> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugType> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pathway> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankIdProtein> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/transmembraneRegions> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalWaterSolubility> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/msdsFiles> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/enzyme> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugReference> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/enzymes> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/bio2rdfSymbol> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/foodInteraction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/toxicity> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/proteinSequence> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightMono> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankIdGene> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/atcCode> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drug_interactions> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/geneSequence> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/brandName> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/cellularLocation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbHomologyId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/reference> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemSubstanceId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/brandedDrug> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/possibleDiseaseTarget> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/generalFunction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> <http://www.w3.org/2002/07/owl#equivalentClass> <http://dbpedia.org/ontology/Drug> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> <http://www.w3.org/2002/07/owl#equivalentClass> <http://www4.wiwiss.fu-berlin.de/dailymed/resource/dailymed/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pfamDomainFunction> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://dbpedia.org/ontology/pfamLink> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pfamDomainFunction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/text> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionDrug2> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/goClassificationComponent> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/generalReference> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/goClassificationFunction> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> <http://www.w3.org/2002/07/owl#equivalentClass> <http://dbpedia.org/ontology/Drug> .
<http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> <http://www.w3.org/2002/07/owl#equivalentClass> <http://www4.wiwiss.fu-berlin.de/dailymed/resource/dailymed/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/references> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogs> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/brandMixture> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/hprdId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/geneName> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/signal> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chebiId> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/name> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeight> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/numberOfResidues> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/absorption> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiIdentifier> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankIdProteinPage> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionDrug1> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Lepirudin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P01050> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P01050> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:120993-53-5> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Lepirudin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringIsomeric> "CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N3)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemSubstanceId> "14818038" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the treatment of heparin-induced thrombocytopenia" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Lepirudin is identical to natural hirudin except for substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-08-26 20:56:02 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/biotransformation> "Lepirudin is thought to be metabolized by release of amino acids via catabolic hydrolysis of the parent drug. However, con-clusive data are not available. About 48% of the administration dose is excreted in the urine which consists of unchanged drug (35%) and other fragments of the parent drug." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> "http://129.128.185.122/drugbank2/drugs/DB00001/inserts/501/full" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www.w3.org/2000/01/rdf-schema#label> "Lepirudin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiKey> "XYWBJDRHGNULKG-JWTJQKDBDD" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA450195" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/toxicity> "In case of overdose (eg, suggested by excessively high aPTT values) the risk of bleeding is increased." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringCanonical> "CCC(C)C1NC(=O)C2CSSCC(NC(=O)C(CC(C)C)NC(=O)C3CSSCC(NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC4=CC=C(O)C=C4)NC(=O)C(NC(=O)C(N)C(C)C)C(C)C)C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCC(O)=O)C(=O)NC(CO)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)N3)C(=O)NC(CCC(O)=O)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(N)=O)C(=O)NC(C(C)C)C(=O)NC(CSSCC(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCC(O)=O)NC(=O)CNC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(C)C)NC1=O)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NCC(=O)NC(C(C)O)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NC(CO)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(N)=O)C(=O)NC(CC(O)=O)C(=O)NCC(=O)NC(CC(O)=O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCC(O)=O)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)CC)C(=O)N1CCCC1C(=O)NC(CCC(O)=O)C(=O)NC(CCC(O)=O)C(=O)NC(CC1=CC=C(O)C=C1)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(O)=O)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(CC(N)=O)C(=O)NC(CCCCN)C(=O)N2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "ITH1_HIRME" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemCompoundId> "16132441" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiIdentifier> "InChI=1/C287H440N80O110S6/c1-25-133(19)226-281(470)345-161(87-125(3)4)235(424)306-111-208(395)320-180(116-370)266(455)344-175(101-219(415)416)237(426)307-105-202(389)316-151(62-75-212(401)402)242(431)321-145(41-30-33-81-288)240(429)339-170(96-197(297)384)258(447)326-152(57-70-193(293)380)249(438)351-185(121-481-478-118-182-239(428)310-107-201(388)313-147(55-68-191(291)378)232(421)303-108-205(392)317-169(95-196(296)383)257(446)322-146(42-31-34-82-289)241(430)350-186(271(460)360-226)122-482-479-119-183(268(457)323-149(61-74-211(399)400)234(423)304-110-207(394)319-179(115-369)265(454)342-173(99-200(300)387)264(453)357-223(130(13)14)279(468)355-182)352-253(442)164(90-128(9)10)335-269(458)184-120-480-483-123-187(354-262(451)177(103-221(419)420)347-283(472)230(137(23)374)362-263(452)167(93-141-49-53-144(377)54-50-141)346-278(467)224(131(15)16)359-276(465)222(301)129(11)12)272(461)363-229(136(22)373)282(471)330-157(66-79-216(409)410)248(437)348-178(114-368)238(427)309-106-203(390)315-150(56-69-192(292)379)243(432)340-171(97-198(298)385)259(448)334-163(89-127(7)8)252(441)353-184)270(459)358-225(132(17)18)280(469)364-228(135(21)372)277(466)311-112-204(391)314-148(60-73-210(397)398)233(422)305-113-209(396)356-231(138(24)375)286(475)367-86-38-46-190(367)275(464)331-159(43-32-35-83-290)284(473)365-84-36-44-188(365)273(462)328-153(58-71-194(294)381)247(436)349-181(117-371)267(456)338-168(94-142-104-302-124-312-142)256(445)341-172(98-199(299)386)260(449)343-174(100-218(413)414)236(425)308-109-206(393)318-176(102-220(417)418)261(450)337-165(91-139-39-28-27-29-40-139)254(443)327-154(63-76-213(403)404)244(433)325-158(67-80-217(411)412)250(439)361-227(134(20)26-2)285(474)366-85-37-45-189(366)274(463)329-156(65-78-215(407)408)245(434)324-155(64-77-214(405)406)246(435)336-166(92-140-47-51-143(376)52-48-140)255(444)333-162(88-126(5)6)251(440)332-160(287(476)477)59-72-195(295)382/h27-29,39-40,47-54,104,124-138,145-190,222-231,368-377H,25-26,30-38,41-46,55-103,105-123,288-290,301H2,1-24H3,(H2,291,378)(H2,292,379)(H2,293,380)(H2,294,381)(H2,295,382)(H2,296,383)(H2,297,384)(H2,298,385)(H2,299,386)(H2,300,387)(H,302,312)(H,303,421)(H,304,423)(H,305,422)(H,306,424)(H,307,426)(H,308,425)(H,309,427)(H,310,428)(H,311,466)(H,313,388)(H,314,391)(H,315,390)(H,316,389)(H,317,392)(H,318,393)(H,319,394)(H,320,395)(H,321,431)(H,322,446)(H,323,457)(H,324,434)(H,325,433)(H,326,447)(H,327,443)(H,328,462)(H,329,463)(H,330,471)(H,331,464)(H,332,440)(H,333,444)(H,334,448)(H,335,458)(H,336,435)(H,337,450)(H,338,456)(H,339,429)(H,340,432)(H,341,445)(H,342,454)(H,343,449)(H,344,455)(H,345,470)(H,346,467)(H,347,472)(H,348,437)(H,349,436)(H,350,430)(H,351,438)(H,352,442)(H,353,441)(H,354,451)(H,355,468)(H,356,396)(H,357,453)(H,358,459)(H,359,465)(H,360,460)(H,361,439)(H,362,452)(H,363,461)(H,364,469)(H,397,398)(H,399,400)(H,401,402)(H,403,404)(H,405,406)(H,407,408)(H,409,410)(H,411,412)(H,413,414)(H,415,416)(H,417,418)(H,419,420)(H,476,477)/t133-,134-,135+,136+,137+,138+,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,222-,223-,224-,225-,226-,227-,228-,229-,230-,231-/m0/s1/f/h303-364,397,399,401,403,405,407,409,411,413,415,417,419,476H,291-300H2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C287H440N80O110S6" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightMono> "6958.962" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "5HIR" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Lepirudin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "6963.425" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "(4S)-4-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[(2R)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-6-amino-2-[[(2S)-4-amino-2-[[2-[[(2S)-5-amino-2-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-4-hydroxy-4-oxobutanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxybutanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]-3-methylbutanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-4-oxobutanoyl]amino]hexanoyl]amino]-3-sulfanylpropanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-hydroxy-4-oxobutanoyl]amino]acetyl]amino]-5-hydroxy-5-oxopentanoyl]amino]hexanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-5-hydroxy-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-hydroxy-4-oxobutanoyl]amino]acetyl]amino]-4-hydroxy-4-oxobutanoyl]amino]-3-cyclohexylpropanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-hydroxy-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-hydroxy-1,5-dioxopentan-2-yl]amino]-5-oxopentanoic acid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "65 oC (Otto, A. & Seckler, R. Eur. J. Biochem. 202:67-73 (1991))" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/absorption> "Bioavailability is 100% following injection." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "1997-09-01\t/drugs/1/fda_labels/402" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.777" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "4.04" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Lepirudin is used to break up clots and to reduce thrombocytopenia. It binds to thrombin and prevents thrombus or clot formation. It is a highly potent, selective, and essentially irreversible inhibitor of thrombin and clot-bond thrombin. Lepirudin requires no cofactor for its anticoagulant action." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Lepirudin forms a stable non-covalent complex with alpha-thrombin, thereby abolishing its ability to cleave fibrinogen and initiate the clotting cascade." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00001 sequence\nLVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSHNDGDFEEIP\nEEYLQ" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "Approximately 1.3 hours" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02240996" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00001" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00001/inserts/1430/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00001/inserts/2428/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00001> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Lepirudin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00001> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/lepirudin.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Cetuximab> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:205923-56-4> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Cetuximab> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For treatment of metastatic colorectal cancer." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-19 16:48:31 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www.w3.org/2000/01/rdf-schema#label> "Cetuximab" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10040" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/toxicity> "Single doses of cetuximab higher than 500 mg/m<sup>2</sup> have not been tested. There is no experience with overdosage in human clinical trials." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/synthesisReference> "Sequence listed in Goldstein N. I., Prewett M., Zuklys K., Rockwell P., Mendelsohn J. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin. Cancer Res., 1: 1311-1318, 1995. (PMID: 9815926); Patent 6,217,866" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C6484H10042N1732O2023S36" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "J00228" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Cetuximab" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "145781.6" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Humanized anti-EGF receptor (EGFr) antibody" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "61 oC (FAB fragment), 71 oC (whole mAb) - Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000)." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "2004-02-01\t/drugs/2/fda_labels/814" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.413" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "8.48" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Used in the treatment of colorectal cancer, cetuximab binds specifically to the epidermal growth factor receptor (EGFr, HER1, c-ErbB-1) on both normal and tumor cells. EGFr is over-expressed in many colorectal cancers. Cetuximab competitively inhibits the binding of epidermal growth factor (EGF) and other ligands, such as transforming growth factor\uFFFD\uFFFD\uFFFDalpha. Binding of cetuximab to the EGFr blocks phosphorylation and activation of receptor-associated kinases, resulting in inhibition of cell growth, induction of apoptosis, decreased matrix metalloproteinase secretion and reduced vascular endothelial growth factor production." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Cetuximab binds to the epidermal growth factor receptor (EGFr) on both normal and tumor cells. EGFr is over-expressed in many colorectal cancers. Cetuximab competitively inhibits the binding of epidermal growth factor (EGF) and TGF alpha, thereby reducing their effects on cell growth and metastatic spread." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">Anti-EGFR heavy chain 1\nQVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYN\nTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSAA\nSTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG\nLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSPKSCDKTHTCPPCPAPELL\nGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQ\nYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSR\nDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKS\nRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK\n>Anti-EGFR heavy chain 2\nQVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYN\nTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSAA\nSTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG\nLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSPKSCDKTHTCPPCPAPELL\nGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQ\nYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSR\nDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKS\nRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK\n>Anti-EGFR light chain 1\nDILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPS\nRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPP\nSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT\nLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGA\n>Anti-EGFR light chain 2\nDILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPS\nRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPP\nSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT\nLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGA" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "114 hrs" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00002" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00002/inserts/865/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00002/inserts/1886/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00002> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Cetuximab> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00002> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic3/erbitux.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Dornase_alfa> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P24855> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P24855> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:9003-98-9> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Dornase_alfa> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the treatment of cystic fibrosis." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Recombinant human deoxyribonuclease I. Delivered by aerosol mist. The protein is produced by genetically engineered Chinese Hamster Ovary (CHO) cells containing DNA encoding for the native human protein, deoxyribonuclease I (DNase). 260 residues" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2007-10-22 02:38:38 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> "http://129.128.185.122/drugbank2/drugs/DB00003/inserts/49/full" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www.w3.org/2000/01/rdf-schema#label> "Dornase Alfa" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10318" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "DNAS1_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbHomologyId> "2DNJ_A" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C1321H1999N339O396S9" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "M55983" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Dornase Alfa" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "29253.9" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Human deoxyribonuclease I" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "67 oC (Chan, H.K. et al., Pharm Res. 13:756-761 (1996))" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "3" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.083" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "4.58" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Cystic fibrosis (CF) is a disease characterized by the retention of viscous purulent secretions in the airways. These thick secretions contribute both to reduced pulmonary function and to frequent pulmonary infection. Purulent pulmonary secretions contain very high concentrations of extracellular DNA released by degenerating leukocytes that accumulate in response to these infections. Dornase Alfa hydrolyzes the DNA in sputum of CF patients and reduces sputum viscoelasticity." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Dornase Alfa hydrolyzes DNA, thereby degrading large, viscous DNA molecules into small, soluble fragments that are easily cleared from the lungs." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00003 sequence\nLKIAAFNIQTFGETKMSNATLVSYIVQILSRYDIALVQEVRDSHLTAVGKLLDNLNQDAP\nDTYHYVVSEPLGRNSYKERYLFVYRPDQVSAVDSYYYDDGCEPCGNDTFNREPAIVRFFS\nRFTEVREFAIVPLHAAPGDAVAEIDALYDVYLDVQEKWGLEDVMLMGDFNAGCSYVRPSQ\nWSSIRLWTSPTFQWLIPDSADTTATPTHCAYDRIVVAGMLLRGAVVPDSALPFNFQAAYG\nLSDQLAQAISDHYPVEVMLK" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02046733" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00003" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00003/inserts/773/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00003/inserts/1796/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00003> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Dornase_alfa> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00003> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/pulmozyme.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Denileukin_diftitox> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P00587> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P00587> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:173146-27-5> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Denileukin_diftitox> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For treatment of cutaneous T-cell lymphoma" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "A recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-19 16:48:56 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www.w3.org/2000/01/rdf-schema#label> "Denileukin diftitox" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10317" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "DTX_COROM" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C2560H4042N678O799S17" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "V01536" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "1F0L" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Denileukin diftitox" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "57647.3" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Diptheria toxin-Interleukin-2 fusion protein" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "4" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "2004-03-01\t/drugs/4/fda_labels/126" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.301" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "5.45" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Denileukin diftitox (Ontak) directs the cytocidal action of diphtheria toxin to cells which express the IL-2 receptor. The human IL-2 receptor exists in three forms, low (CD25), intermediate (CD122/CD132) and high (CD25/CD122/CD132) affinity. Malignant cells expressing one or more of the subunits of the IL-2 receptor are found in certain leukemias and lymphomas including cutaneous T-cell lymphoma (CTCL). Ontak interacts with the high affinity IL-2 receptor on the cell surface and inhibits cellular protein synthesis, resulting in cell death within hours." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Ontak binds to the high-affinity IL-2 receptor complex. The IL-2 receptor (Tac) subunit is expressed on activated but not resting lymphocytes. The diphtheria toxin associated with Ontak then selectively kills the IL-2 bearing cells." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00004 sequence\nMGADDVVDSSKSFVMENFSSYHGTKPGYVDSIQKGIQKPKSGTQGNYDDDWKGFYSTDNK\nYDAAGYSVDNENPLSGKAGGVVKVTYPGLTKVLALKVDNAETIKKELGLSLTEPLMEQVG\nTEEFIKRFGDGASRVVLSLPFAEGSSSVEYINNWEQAKALSVELEINFETRGKRGQDAMY\nEYMAQACAGNRVRRSVGSSLSCINLDWDVIRDKTKTKIESLKEHGPIKNKMSESPNKTVS\nEEKAKQYLEEFHQTALEHPELSELKTVTGTNPVFAGANYAAWAVNVAQVIDSETADNLEK\nTTAALSILPGIGSVMGIADGAVHHNTEEIVAQSIALSSLMVAQAIPLVGELVDIGFAAYN\nFVESIINLFQVVHNSYNRPAYSPGHKTHAPTSSSTKKTQLQLEHLLLDLQMILNGINNYK\nNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVI\nVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "70-80 min" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00004" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00004/inserts/937/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00004/inserts/1954/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00004> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Denileukin_diftitox> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00004> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic2/denileukin.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Etanercept> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P20333> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P20333> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:185243-69-0> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggDrugId> <http://bio2rdf.org/kegg:D00742> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggCompoundId> <http://bio2rdf.org/cpd:C07897> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Etanercept> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemSubstanceId> "10099" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For treatment of severe adult and juvenille rheumatoid arthritis" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1. Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of 934 amino acids" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-19 16:46:08 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> "http://129.128.185.122/drugbank2/drugs/DB00005/inserts/659/full" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www.w3.org/2000/01/rdf-schema#label> "Etanercept" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA449515" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "TNR1B_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C2224H3475N621O698S36" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "M32315" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Etanercept" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "51234.9" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Human tumor necrosis factor receptor fusion protein" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "71 oC (whole mAb) - Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000)." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "5" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.529" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "7.89" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Used in the treatment of rheumatoid arthritis and the reduction of the adverse effects of tumor necrosis factor (TNF). TNF is a naturally occurring cytokine that is involved in normal inflammatory and immune responses. Elevated levels of TNF are found in tissues and fluids of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (AS), and plaque psoriasis. Etanercept binds specifically to tumor necrosis factor (TNF) and blocks its interaction with cell surface TNF receptors." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "There are two distinct receptors for TNF (TNFRs), a 55 kilodalton protein (p55) and a 75 kilodalton protein (p75). The biological activity of TNF is dependent upon binding to either cell surface receptor (p75 or p55). Etanercept is a dimeric soluble form of the p75 TNF receptor that can bind to two TNF molecules, thereby effectively removing them from circulation." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00005 sequence\nLPAQVAFTPYAPEPGSTCRLREYYDQTAQMCCSKCSPGQHAKVFCTKTSDTVCDSCEDST\nYTQLWNWVPECLSCGSRCSSDQVETQACTREQNRICTCRPGWYCALSKQEGCRLCAPLRK\nCRPGFGVARPGTETSDVVCKPCAPGTFSNTTSSTDICRPHQICNVVAIPGNASMDAVCTS\nTSPTRSMAPGAVHLPQPVSTRSQHTQPTPEPSTAPSTSFLLPMGPSPPAEGSTGDEPKSC\nDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPQVKFNWYVD\nGVQVHNAKTKPREQQYNSTYRVVSVLTVLHQNWLDGKEYKCKVSNKALPAPIEKTISKAK\nGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDS\nDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "102 +/- 30 hrs" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02242903" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00005" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00005/inserts/1652/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00005/inserts/2634/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00005> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Etanercept> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00005> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/etanercept.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Bivalirudin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:128270-60-0> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Bivalirudin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringIsomeric> "[H]N=C(/N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemSubstanceId> "214065" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For treatment of heparin-induced thrombocytopenia" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Synthetic 20 residue peptide (thrombin inhibitor)" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedWaterSolubility> "4.64e-02 mg/mL" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-08-26 16:12:51 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogpHydrophobicity> "-0.75" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www.w3.org/2000/01/rdf-schema#label> "Bivalirudin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiKey> "OIRCOABEOLEUMC-OIAMKPTGDH" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10032" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringCanonical> "[H]N=C(N)NCCCC(NC(=O)C1CCCN1C(=O)C(N)CC1=CC=CC=C1)C(=O)N1CCCC1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NC(CC(N)=O)C(=O)NCC(=O)NC(CC(O)=O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCC(O)=O)C(=O)NC(CCC(O)=O)C(=O)NC(C(C)CC)C(=O)N1CCCC1C(=O)NC(CCC(O)=O)C(=O)NC(CCC(O)=O)C(=O)NC(CC1=CC=C(O)C=C1)C(=O)NC(CC(C)C)C(O)=O" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemCompoundId> "16129704" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiIdentifier> "InChI=1/C98H138N24O33/c1-5-52(4)82(96(153)122-39-15-23-70(122)92(149)114-60(30-34-79(134)135)85(142)111-59(29-33-78(132)133)86(143)116-64(43-55-24-26-56(123)27-25-55)89(146)118-67(97(154)155)40-51(2)3)119-87(144)61(31-35-80(136)137)112-84(141)58(28-32-77(130)131)113-88(145)63(42-54-18-10-7-11-19-54)117-90(147)66(45-81(138)139)110-76(129)50-107-83(140)65(44-71(100)124)109-75(128)49-106-73(126)47-104-72(125)46-105-74(127)48-108-91(148)68-21-13-38-121(68)95(152)62(20-12-36-103-98(101)102)115-93(150)69-22-14-37-120(69)94(151)57(99)41-53-16-8-6-9-17-53/h6-11,16-19,24-27,51-52,57-70,82,123H,5,12-15,20-23,28-50,99H2,1-4H3,(H2,100,124)(H,104,125)(H,105,127)(H,106,126)(H,107,140)(H,108,148)(H,109,128)(H,110,129)(H,111,142)(H,112,141)(H,113,145)(H,114,149)(H,115,150)(H,116,143)(H,117,147)(H,118,146)(H,119,144)(H,130,131)(H,132,133)(H,134,135)(H,136,137)(H,138,139)(H,154,155)(H4,101,102,103)/t52-,57+,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,82-/m0/s1/f/h101,103-119,130,132,134,136,138,154H,100,102H2/b101-98+" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C98H138N24O33" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightMono> "2178.9858" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "2HGT" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Bivalirudin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "2180.2853" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[2-[[2-[[2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2R)-2-amino-3-cyclohexylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-4-hydroxy-4-oxobutanoyl]amino]-3-cyclohexylpropanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-5-hydroxy-5-oxopentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoic acid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "6" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "2000-12-01\t/drugs/6/fda_labels/945" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.985" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "3.91" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Angiomax directly inhibits thrombin by specifically binding both to the catalytic site and to the anion-binding exosite of circulating and clot-bound thrombin. Thrombin is a serine proteinase that plays a central role in the thrombotic process, acting to cleave fibrinogen into fibrin monomers and to activate Factor XIII to Factor XIIIa, allowing fibrin to develop a covalently cross-linked framework which stabilizes the thrombus; thrombin also activates Factors V and VIII, promoting further thrombin generation, and activates platelets, stimulating aggregation and granule release" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Inhibits the action of thrombin by binding both to its catalytic site and to its anion-binding exosite." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogs> "-4.67" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00006 sequence\nFPRPGGGGNGDFEEIPEEYL" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "25 min (in normal conditions)" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02246533" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00006" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00006/inserts/1510/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00006/inserts/2507/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00006> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Bivalirudin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00006> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/angiomax.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Leuprolide> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:53714-56-0> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggCompoundId> <http://bio2rdf.org/cpd:C07612> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Leuprolide> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringIsomeric> "CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H]1CCC(=O)N1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemSubstanceId> "9814" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Synthetic 9 residue peptide analog of gonadotropin releasing hormone." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedWaterSolubility> "3.24e-02 mg/mL" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-08-26 14:39:49 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogpHydrophobicity> "1.01" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www.w3.org/2000/01/rdf-schema#label> "Leuprolide" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiKey> "GFIJNRVAKGFPGQ-SMWJGGTOCQ" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA450202" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringCanonical> "CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC1=CNC2=CC=CC=C12)NC(=O)C(CC1=CN=CN1)NC(=O)C1CCC(=O)N1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemCompoundId> "3911" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/proteinBinding> "46%" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiIdentifier> "InChI=1/C59H84N16O12/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64)/f/h63,66-74H,60-61H2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C59H84N16O12" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightMono> "1208.6455" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Leuprolide" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "1209.3983" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "7" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "2000-03-01\t/drugs/7/fda_labels/307\n2001-09-01\t/drugs/7/fda_labels/160\n2002-01-01\t/drugs/7/fda_labels/654\n2002-07-01\t/drugs/7/fda_labels/587\n2003-02-01\t/drugs/7/fda_labels/700\n2003-05-01\t/drugs/7/fda_labels/99\n2004-04-01\t/drugs/7/fda_labels/786" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "0.1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Used in the palliative treatment of advanced prostate cancer. Leuprolide is a luteinizing hormone agonist that results in suppression of testicular or follicular steroidogenesis." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Leuprolide binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogs> "-4.57" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "~3 hours" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00007" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00007/inserts/998/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00007> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Leuprolide> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00007> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/eligard.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Peginterferon_alfa-2a> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P01563> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P01563> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:198153-51-4> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Peginterferon_alfa-2a> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Human interferon 2a, is a covalent conjugate of recombinant alfa-2a interferon with a single branched bis-monomethoxy polyethylene glycol (PEG) chain. The PEG moiety is linked at a single site to the interferon alfa moiety via a stable amide bond to lysine. Peginterferon alfa-2a has an approximate molecular weight of 60,000 daltons. Interferon alfa-2a is produced using recombinant DNA technology in which a cloned human leukocyte interferon gene is inserted into and expressed in Escherichia coli. The resultant protein is 165 amino acids. The PEG strand protects the molecule in vivo from proteolytic breakdown, substantially increases its in vivo half-life, and reduces immunogenicity by wrapping around and physically hindering access to the protein portion of the molecule." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-17 14:05:07 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> "http://129.128.185.122/drugbank2/drugs/DB00008/inserts/77/full" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www.w3.org/2000/01/rdf-schema#label> "Peginterferon alfa-2a" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10152" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "IFNA2_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "J00207" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "1ITF" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Peginterferon alfa-2a" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "60000.0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "61 oC (Beldarrain, A. et al., Biochemistry 38:7865-7873 (1999))Davis JM, Narachi MA, Levine HL, Alton NK, Arakawa T. Conformation and stability of two recombinant human interferon-alpha analogs." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "8" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "5.99" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2'-5' oligoadenylate synthetase (2'-5' A synthetase) and protein kinase R." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which, upon dimerization, activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription) which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon alpha binds less stably to type I interferon receptors than interferon beta." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00008 sequence\nCDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMI\nQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVR\nKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "Terminal half life is 80 hours (range 50 to 140 hours)." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02248077" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00008" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00008/inserts/817/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00008/inserts/1837/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00008> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Peginterferon_alfa-2a> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00008> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic3/pegasys.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Alteplase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P00750> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P00750> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:105857-23-6> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggDrugId> <http://bio2rdf.org/kegg:D02837> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Alteplase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For management of acute myocardial infarction, acute ischemic strok and for lysis of acute pulmonary emboli" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2007-10-22 02:38:39 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> "http://129.128.185.122/drugbank2/drugs/DB00009/inserts/47/full" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www.w3.org/2000/01/rdf-schema#label> "Alteplase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10012" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "TPA_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C2569H3928N746O781S40" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "L00153" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Alteplase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "59042.3" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "60 oC (Novokhatny, V.V. et al., J. Biol. Chem. 266:12994-123002 (1991))" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "9" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "2004-03-01\t/drugs/9/fda_labels/107" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.516" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "7.61" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Activase binds to fibrin in a thrombus and converts the entrapped plasminogen to plasmin. It also produces limited conversion of plasminogen in the absence of fibrin." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Cleaves the Arg-Val bond in plasminogen to produce active plasmin." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00009 sequence\nSYQVICRDEKTQMIYQQHQSWLRPVLRSNRVEYCWCNSGRAQCHSVPVKSCSEPRCFNGG\nTCQQALYFSDFVCQCPEGFAGKCCEIDTRATCYEDQGISYRGTWSTAESGAECTNWNSSA\nLAQKPYSGRRPDAIRLGLGNHNYCRNPDRDSKPWCYVFKAGKYSSEFCSTPACSEGNSDC\nYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDGDAK\nPWCHVLKNRRLTWEYCDVPSCSTCGLRQYSQPQFRIKGGLFADIASHPWQAAIFAKHRRS\nPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVH\nKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYGKHEAL\nSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGG\nPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNMRP" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02245859" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00009" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00009/inserts/771/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00009/inserts/1794/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00009> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Alteplase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00009> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/alteplas.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Sermorelin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:86168-78-7> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggCompoundId> <http://bio2rdf.org/cpd:C08192> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Sermorelin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringIsomeric> "CC[C@@H](C)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemSubstanceId> "10391" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the treatment of dwarfism, prevention of HIV-induced weight loss" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Sermorelin acetate is the acetate salt of an amidated synthetic 29-amino acid peptide (GRF 1-29 NH 2 ) that corresponds to the amino-terminal segment of the naturally occurring human growth hormone-releasing hormone (GHRH or GRF) consisting of 44 amino acid residues" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedWaterSolubility> "5.98e-02 mg/mL" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-08-26 15:09:49 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogpHydrophobicity> "-1.07" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www.w3.org/2000/01/rdf-schema#label> "Sermorelin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiKey> "WGWPRVFKDLAUQJ-QCADAVOKCE" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA451331" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringCanonical> "CCC(C)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(C)NC(=O)C(N)CC1=CC=C(O)C=C1)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(CC1=CC=C(O)C=C1)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CC(O)=O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(N)=N)C(N)=O" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemCompoundId> "16129620" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiIdentifier> "InChI=1/C149H246N44O42S/c1-20-77(13)116(191-122(211)81(17)168-132(221)104(66-113(204)205)178-121(210)79(15)167-123(212)88(152)62-84-39-43-86(198)44-40-84)145(234)185-102(63-83-32-23-22-24-33-83)138(227)193-118(82(18)197)146(235)186-103(65-111(155)202)137(226)189-108(71-196)142(231)182-101(64-85-41-45-87(199)46-42-85)136(225)175-93(38-31-56-165-149(161)162)126(215)174-91(35-26-28-53-151)131(220)190-115(76(11)12)143(232)184-97(58-72(3)4)124(213)166-68-112(203)170-94(47-49-109(153)200)128(217)180-100(61-75(9)10)135(224)188-106(69-194)140(229)169-80(16)120(209)172-92(37-30-55-164-148(159)160)125(214)173-90(34-25-27-52-150)127(216)179-99(60-74(7)8)134(223)181-98(59-73(5)6)133(222)176-95(48-50-110(154)201)129(218)183-105(67-114(206)207)139(228)192-117(78(14)21-2)144(233)177-96(51-57-236-19)130(219)187-107(70-195)141(230)171-89(119(156)208)36-29-54-163-147(157)158/h22-24,32-33,39-46,72-82,88-108,115-118,194-199H,20-21,25-31,34-38,47-71,150-152H2,1-19H3,(H2,153,200)(H2,154,201)(H2,155,202)(H2,156,208)(H,166,213)(H,167,212)(H,168,221)(H,169,229)(H,170,203)(H,171,230)(H,172,209)(H,173,214)(H,174,215)(H,175,225)(H,176,222)(H,177,233)(H,178,210)(H,179,216)(H,180,217)(H,181,223)(H,182,231)(H,183,218)(H,184,232)(H,185,234)(H,186,235)(H,187,219)(H,188,224)(H,189,226)(H,190,220)(H,191,211)(H,192,228)(H,193,227)(H,204,205)(H,206,207)(H4,157,158,163)(H4,159,160,164)(H4,161,162,165)/f/h157,159,161,163-193,204,206H,153-156,158,160,162H2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C149H246N44O42S" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightMono> "3355.8187" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Sermorelin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "3357.882" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "3-[[5-amino-2-[[2-[[2-[[6-amino-2-[[2-[2-[[2-[[2-[[5-amino-2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[[2-[[4-amino-2-[[2-[[2-[[2-[2-[[2-[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoylamino]-4-hydroxy-4-oxobutanoyl]amino]propanoylamino]-3-methylpentanoyl]amino]-3-cyclohexylpropanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]propanoylamino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-[[1-[[1-[[1-[(1-amino-5-carbamimidamido-1-oxopentan-2-yl)amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "10" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.330" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "9.99" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Sermorelin is used in the treatment of children with growth hormone deficiency or growth failure. Geref increases plasma growth hormone (GH) concentration by stimulating the pituitary gland to release GH. Geref is similar to the full-length native hormone (44 residues) in its ability to stimulate GH secretion in humans." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Sermorelin binds to the growth hormone releasing hormone receptor and mimics native GRF in its ability to stimulate growth hormone secretion." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogs> "-4.75" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00010 sequence\nYADAIFTNSYRKVLGQLSARKLLQDIMSRQ" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "11-12 min" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00010" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00010/inserts/1658/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00010/inserts/2640/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00010> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Sermorelin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00010> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic2/sermorelin.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P01563> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P01563> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:74899-72-2> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For treatment of venereal or genital warts caused by the Human Papiloma Virus" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Purified, natural (n is for natural) glycosylated human interferon alpha proteins 166 residues" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-17 14:07:27 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www.w3.org/2000/01/rdf-schema#label> "Interferon alfa-n1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10274" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "IFNA2_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/synthesisReference> "Davis JM, Narachi MA, Levine HL, Alton NK, Arakawa T. Conformation and stability of two recombinant human interferon-alpha analogs.\nInt J Pept Protein Res. 1987 Jun;29(6):685-91." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C860H1353N227O255S9" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "J00207" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "1ITF" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Interferon alfa-n1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "19241.1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "Melting point: 61 oC (Beldarrain, A. et al., Biochemistry 38:7865-7873 (1999))" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "11" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.336" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "5.99" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2'-5' oligoadenylate synthetase (2'-5' A synthetase) and protein kinase R." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which, upon dimerization, activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription)which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon alpha binds less stably to type I interferon receptors than interferon beta." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00011 sequence\nCDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMI\nQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVR\nKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "1.2 hours (mammalian reticulocytes, in vitro); &gt;20 hours (yeast, in vivo); &gt;10 hours (Escherichia coli, in vivo)." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "01959077" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00011" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00011> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00011> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Darbepoetin_alfa> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P01588> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P01588> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:11096-26-7> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Darbepoetin_alfa> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the treatment of anemia (from renal transplants or certain HIV treatment)" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2007-11-18 20:25:11 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> "http://129.128.185.122/drugbank2/drugs/DB00012/inserts/170/full" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www.w3.org/2000/01/rdf-schema#label> "Darbepoetin alfa" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10801" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "EPO_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C815H1317N233O241S5" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "X02158" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "1BUY" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Darbepoetin alfa" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "18396.1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Human erythropoietin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "53 oC (Arakawa, T. et al., Biosci. Biotechnol. Biochem. 65:1321-1327 (2001))." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "12" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.188" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "8.75" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Darbepoetin alfa is used in the treatment of anemia. It is involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Darbepoetin alfa stimulates erythropoiesis by the same mechanism as endogenous erythropoietin. Erythropoietin interacts with\nprogenitor stem cells to increase red cell production. Binding of erythropoietin to the erythropoietin receptor leads to receptor dimerization, which facilitates activation of JAK-STAT signaling pathways within the cytosol. Activated STAT (signal transducers and activators of transcription) proteins are then translocated to the nucleus where they serve as transcription factors which regulate the activation of specific genes involved in cell division or differentiation." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00012 sequence\nAPPRLICDSRVLERYLLEAKEAENITTGCAEHCSLNENITVPDTKVNFYAWKRMEVGQQA\nVEVWQGLALLSEAVLRGQALLVNSSQPWEPLQLHVDKAVSGLRSLTTLLRALGAQKEAIS\nPPDAASAAPLRTITADTFRKLFRVYSNFLRGKLKLYTGEACRTGDR" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02246360" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00012" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00012/inserts/949/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00012/inserts/1965/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00012> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Darbepoetin_alfa> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00012> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/aranesp.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Urokinase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P00749> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P00749> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:9039-53-6> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Urokinase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the treatment of pulminary embolism, coronary artery thrombosis and IV catheter clearance" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Low molecular weight form of human urokinase, that consists of an A chain of 2,000 daltons linked by a sulfhydryl bond to a B chain of 30,400 daltons. Recombinant urokinase plasminogen activator" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-19 16:31:13 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/biotransformation> "Proteolysis" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www.w3.org/2000/01/rdf-schema#label> "Urokinase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA451836" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "UROK_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/synthesisReference> "PMID 2987867" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C1376H2145N383O406S18" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "X02419" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "1VJA" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Urokinase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "31126.5" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Human urokinase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "76 oC at pH 4.5 (Nowak, U.K. et al., Biochemistry 33:2951-2960 (1994)." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "13" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.466" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "8.66" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Urokinase is used for the treatment of pulmonary embolisms. The low molecular weight form of human urokinase consists of an A chain of 2,000 daltons linked by a sulfhydryl bond to a B chain of 30,400 daltons. Urokinase is an enzyme (protein) produced by the kidney, and found in the urine. There are two forms of urokinase which differ in molecular weight but have similar clinical effects. Urokinase is the low molecular weight form. Urokinase acts on the endogenous fibrinolytic system. It converts plasminogen to the enzyme plasmin. Plasmin degrades fibrin clots as well as fibrinogen and some other plasma proteins." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Urokinase acts on the endogenous fibrinolytic system. It cleaves the Arg-Val bond in plasminogen to produce active plasmin. Plasmin degrades fibrin clots as well as fibrinogen and other plasma proteins." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00013 sequence\nKPSSPPEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMS\nPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHND\nIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMT\nVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS\nWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "12 minutes. Small fractions of the administered dose are excreted in bile and urine" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "00749702" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00013" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00013> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Urokinase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00013> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/pharmclips2.cgi?keyword=%20Abbokinase%AE> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Goserelin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:65807-02-5> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggDrugId> <http://bio2rdf.org/kegg:D00573> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Goserelin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringIsomeric> "CC(C)C[C@@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H]1CCC(=O)N1)C(=O)N[C@H](CCCN=C(/N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemSubstanceId> "186963" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "Breast cancer; Prostate carcinoma; Endometriosis" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Goserelin is a synthetic hormone. In men, it stops the production of the hormone testosterone, which may stimulate the growth of cancer cells. In women, goserelin decreases the production of the hormone estradiol (which may stimulate the growth of cancer cells) to levels similar to a postmenopausal state. When the medication is stopped, hormone levels return to normal." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedWaterSolubility> "2.83e-02 mg/mL" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-08-26 16:07:49 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/biotransformation> "Hepatic" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> "http://129.128.185.122/drugbank2/drugs/DB00014/inserts/323/full" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogpHydrophobicity> "0.30" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www.w3.org/2000/01/rdf-schema#label> "Goserelin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiKey> "BLCLNMBMMGCOAS-LMKYEUCVCQ" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/toxicity> "No experience of overdosage from clinical trials" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringCanonical> "CC(C)CC(NC(=O)C(COC(C)(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CO)NC(=O)C(CC1=CNC2=CC=CC=C12)NC(=O)C(CC1=CN=CN1)NC(=O)C1CCC(=O)N1)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(N)=O" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemCompoundId> "47725" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/synthesisReference> "Weber et al., U.S. Pat. 3,454,635 (1969)" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Solid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/proteinBinding> "27.3%" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiIdentifier> "InChI=1/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/f/h66-76H,60-62H2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C59H84N18O14" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalWaterSolubility> "Soluble" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightMono> "1268.6414" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Goserelin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "1269.4105" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/absorption> "Inactive orally, rapidly absorbed following subcutaneous administration" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "14" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "1998-07-01\t/drugs/14/fda_labels/772" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "The pharmacokinetics of ZOLADEX have been determined in both male and female healthy volunteers and patients. In these studies, ZOLADEX was administered as a single 250&micro;g (aqueous solution) dose and as a single or multiple 3.6 mg depot dose by subcutaneous route." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "ZOLADEX is a synthetic decapeptide analogue of LHRH. ZOLADEX acts as a potent inhibitor of pituitary gonadotropin secretion when administered in the biodegradable formulation. The result is sustained suppression of LH and serum testosterone levels." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogs> "-4.65" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "4-5 hours" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02225905" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00014" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00014/inserts/1174/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00014/inserts/2181/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00014> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Goserelin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00014> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/goserel.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Reteplase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P00750> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P00750> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:133652-38-7> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Reteplase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Human tissue plasminogen activator, purified, glycosylated, 355 residues purified from CHO cells. Retavase is considered a \"third-generation\" thrombolytic agent, genetically engineered to retain and delete certain portions of human tPA. Retavase is a deletion mutein of human tPA formed by deleting various amino acids present in endogenous human tPA. Retavase contains 355 of the 527 amino acids of native human tPA (amino acids 1-3 and 176-527), and retains the activity-related kringle-2 and serine protease domains of human tPA. Three domains are deleted from retavase - kringle-1, finger, and epidermal growth factor (EGF)." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2007-10-22 02:38:40 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www.w3.org/2000/01/rdf-schema#label> "Reteplase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "TPA_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C1736H2671N499O522S22" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "L00153" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Reteplase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "39589.6" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Human tissue plasminogen activator fragment" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "60 oC (Novokhatny, V.V. et al., J. Biol. Chem. 266:12994-123002 (1991))" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "15" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.435" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "6.86" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Retavase cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. This helps eliminate blood clots or arterial blockages that cause myocardial infarction." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Retavase cleaves the Arg/Val bond in plasminogen to form plasmin. This in turn leads to the degradation of blood clots." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00015 sequence\nSYQGNSDCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYC\nRNPDGDAKPWCHVLKNRRLTWEYCDVPSCSTCGLRQYSQPQFRIKGGLFADIASHPWQAA\nIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKF\nEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELS\nGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHD\nACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNMRP" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02233013" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00015" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00015/inserts/858/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00015/inserts/1879/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00015> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Reteplase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00015> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic2/reteplase.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Epoetin_alfa> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P01588> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P01588> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:113427-24-0> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Epoetin_alfa> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For treatment of anemia (from renal transplants or certain HIV treatment)" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Human erythropoietin (recombinant), produced by CHO cells." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2007-10-22 02:38:40 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www.w3.org/2000/01/rdf-schema#label> "Epoetin alfa" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA449478" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "EPO_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C815H1317N233O241S5" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "X02158" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "1BUY" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Epoetin alfa" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "18396.1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Human erythropoietin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "53 oC (Arakawa, T. et al., Biosci. Biotechnol. Biochem. 65:1321-1327 (2001))." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "16" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "2004-03-01\t/drugs/16/fda_labels/751" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "8.75" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Used in the treatment of anemia. Involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Binding of erythropoietin to the erythropoietin receptor leads to receptor dimerization, which facilitates activation of JAK-STAT signaling pathways within the cytosol. Activated STAT (signal transducers and activators of transcription) proteins are then translocated to the nucleus where they serve as transcription factors which regulate the activation of specific genes involved in cell division or differentiation." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00016 sequence\nAPPRLICDSRVLERYLLEAKEAENITTGCAEHCSLNENITVPDTKVNFYAWKRMEVGQQA\nVEVWQGLALLSEAVLRGQALLVNSSQPWEPLQLHVDKAVSGLRSLTTLLRALGAQKEAIS\nPPDAASAAPLRTITADTFRKLFRVYSNFLRGKLKLYTGEACRTGDR" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02243403" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00016" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00016/inserts/1609/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00016/inserts/2598/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00016> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Epoetin_alfa> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00016> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/epoetin.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Calcitonin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P01263> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P01263> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:47931-85-1> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggDrugId> <http://bio2rdf.org/kegg:D00249> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/keggCompoundId> <http://bio2rdf.org/cpd:C06865> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Calcitonin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringIsomeric> "CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](CO)C(=O)NCC(=O)N[C@H]([C@H](C)O)C(=O)N1CCC[C@@H]1C(N)=O" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemSubstanceId> "7847315" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the treatment of post-menopausal osteoporosis" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Synthetic peptide, 32 residues long formulated as a nasal spray." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedWaterSolubility> "2.61e-01 mg/mL" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-08-26 14:52:54 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/biotransformation> "Salmon calcitonin is primarily and almost exclusively degraded in the kidneys, forming pharmacologically inactive fragments of the molecule." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> "http://129.128.185.122/drugbank2/drugs/DB00017/inserts/149/full" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogpHydrophobicity> "-0.71" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www.w3.org/2000/01/rdf-schema#label> "Salmon Calcitonin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiKey> "BBBFJLBPOGFECG-CDFLCEDYCE" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA448716" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/toxicity> "Salmon calcitonin is devoid of embryotoxic, teratogenic and mutagenic potential." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/smilesStringCanonical> "CC(C)CC(NC(=O)C(NC(=O)C1CSSCC(N)C(=O)NC(CO)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)N1)C(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC1=CN=CN1)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(C)O)C(=O)NC(CC1=CC=C(O)C=C1)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NC(C(C)O)C(=O)NC(CC(N)=O)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N1CCCC1C(N)=O" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "CALC1_ONCKE" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pubchemCompoundId> "16129616" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "1" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/proteinBinding> "30 to 40%" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/inchiIdentifier> "InChI=1/C145H240N44O48S2/c1-65(2)45-86(175-139(232)110(70(11)12)183-136(229)99-63-239-238-62-79(148)117(210)178-96(59-191)134(227)174-92(52-104(151)202)131(224)172-90(49-69(9)10)129(222)180-98(61-193)135(228)187-114(74(16)197)142(235)181-99)118(211)158-55-106(204)162-80(25-18-20-40-146)120(213)169-89(48-68(7)8)128(221)179-97(60-192)133(226)167-83(34-37-102(149)200)122(215)165-85(36-39-109(207)208)123(216)171-88(47-67(5)6)127(220)173-91(51-77-54-156-64-161-77)130(223)164-81(26-19-21-41-147)121(214)170-87(46-66(3)4)126(219)166-84(35-38-103(150)201)125(218)186-113(73(15)196)141(234)177-94(50-76-30-32-78(199)33-31-76)143(236)189-44-24-29-101(189)137(230)168-82(27-22-42-157-145(154)155)124(217)185-112(72(14)195)140(233)176-93(53-105(152)203)132(225)184-111(71(13)194)138(231)160-56-107(205)163-95(58-190)119(212)159-57-108(206)182-115(75(17)198)144(237)188-43-23-28-100(188)116(153)209/h30-33,54,64-75,79-101,110-115,190-199H,18-29,34-53,55-63,146-148H2,1-17H3,(H2,149,200)(H2,150,201)(H2,151,202)(H2,152,203)(H2,153,209)(H,156,161)(H,158,211)(H,159,212)(H,160,231)(H,162,204)(H,163,205)(H,164,223)(H,165,215)(H,166,219)(H,167,226)(H,168,230)(H,169,213)(H,170,214)(H,171,216)(H,172,224)(H,173,220)(H,174,227)(H,175,232)(H,176,233)(H,177,234)(H,178,210)(H,179,221)(H,180,222)(H,181,235)(H,182,206)(H,183,229)(H,184,225)(H,185,217)(H,186,218)(H,187,228)(H,207,208)(H4,154,155,157)/f/h154,157-187,207H,149-153,155H2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C145H240N44O48S2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "Y00765" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightMono> "3429.7133" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "1BYV" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Salmon Calcitonin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "3431.853" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "4-[[5-amino-2-[[2-[[2-[[6-amino-2-[[2-[[2-[[2-[[22-amino-16-(2-amino-2-oxoethyl)-7-(1-hydroxyethyl)-10,19-bis(hydroxymethyl)-13-(2-methylpropyl)-6,9,12,15,18,21-hexaoxo1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-[[1-[[1-[[6-amino-1-[[1-[[5-amino-1-[[1-[[1-[2-[[1-[[1-[[4-amino-1-[[1-[[2-[[1-[[2-[[1-(2-carbamoylpyrrolidin-1-yl)-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/absorption> "Salmon calcitonin is rapidly absorbed and eliminated. Bioavailability following subcutaneous and intramuscular injection in humans is high and similar for the two routes of administration (71% and 66%, respectively)." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "17" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.537" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "8.86" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Calcitonin inhibits bone removal by osteoclasts (bone remodeling cells) and promotes bone formation by osteoblasts. This leads to a net increase in bone mass. Calcitonin also reduces plasma calcium levels and enhances secretion of ions in the kidney." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Calcitonin binds to the calcitonin receptor (found primarily in osteoclasts) which then enhances the production of vitamin D producing enzymes (25-hydroxyvitamine D-24-hydroxylase), leading to greater calcium retention and enhanced bone density. Binding of calcitonin to its receptor also activates adenylyl cyclase and the phosphatidyl-inositol-calcium pathway." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/predictedLogs> "-4.12" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00017 sequence\nCSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "50-80 minutes" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00017" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00017/inserts/917/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00017/inserts/1933/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00017> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Calcitonin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00017> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic2/calcit.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the intralesional treatment of refractory or recurring external condylomata acuminata." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Purified, natural (n is for natural) human interferon alpha proteins (consists of 3 forms or polymorphisms including 2a, 2b and 2c). 166 residues, some are glycosylated (MW range from 16 kD to 27 kD)." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-19 16:33:51 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www.w3.org/2000/01/rdf-schema#label> "Interferon alfa-n3" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10322" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Interferon alfa-n3" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "61 oC (Beldarrain, A. et al., Biochemistry 38:7865-7873 (1999)) Davis JM, Narachi MA, Levine HL, Alton NK, Arakawa T. Conformation and stability of two recombinant human interferon-alpha analogs.Int J Pept Protein Res. 1987 Jun;29(6):685-91." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "18" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "5.99" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Interferon alfa-n3 upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2'-5' oligoadenylate synthetase (2'-5' A synthetase), beta-2 microglobulin, neopterin and protein kinase R." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which, upon dimerization, activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription) which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon alpha binds less stably to type I interferon receptors than interferon beta." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00018 sequence (alpha-2A)\nCDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMI\nQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVR\nKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE\n>DB00018 sequence (alpha-2B)\nCDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMI\nQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMNEDSILAVR\nKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE\n>DB00018 sequence (alpha-2C)\nCDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRRDFGFPQEEFGNQFQKAETIPVLHEMI\nQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMNEDSILAVR\nKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00018" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00018> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00018> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Pegfilgrastim> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P09919> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P09919> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:208265-92-3> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Pegfilgrastim> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "Increases leukocyte production, for treatment in non-myeloid cancer, neutropenia and bone marrow transplant" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "PEGylated (at N terminus) form of human G-CSF (Granulocyte colony stimulating factor), 175 residues, produced from E. coli via bacterial fermentation." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2007-10-22 02:38:40 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/patientInformationInsert> "http://129.128.185.122/drugbank2/drugs/DB00019/inserts/690/full" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www.w3.org/2000/01/rdf-schema#label> "Pegfilgrastim" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10809" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "CSF3_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C845H1343N223O243S9" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "X03438" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "1PGR" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Pegfilgrastim" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "18802.8" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "PEGylated human granulocyte colony stimulating factor" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "60 oC (Luo, P., Protein Science 11:1218-1226 (2002))" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "19" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "2004-03-01\t/drugs/19/fda_labels/408" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "0.209" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "5.65" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Used in the treatment of chemotherapy-induced neutropenia by enhancing the production of neutrophils. Pegfilgrastim acts on hematopoietic cells by binding to specific cell surface receptors thereby stimulating proliferation, differentiation, commitment, and end cell functional activation. Pegfilgrastim has reduced renal clearance and prolonged persistence in vivo as compared to Filgrastim." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Pegfilgrastim binds to the G-CSF receptor. As a G-CSF analog, it controls proliferation of committed progenitor cells and influences their maturation into mature neutrophils. Pegfilgrastim also stimulates the release of neutrophils from bone marrow storage pools and reduces their maturation time. Pegfilgrastim acts to increase the phagocytic activity of mature neutrophils. In patients receiving cytotoxic chemotherapy, pegfilgrastim can accelerate neutrophil recovery, leading to a reduction in duration of the neutropenic phase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00019 sequence\nMTPLGPASSLPQSFLLKCLEQVRKIQGDGAALQEKLCATYKLCHPEELVLLGHSLGIPWA\nPLSSCPSQALQLAGCLSQLHSGLFLYQGLLQALEGISPELGPTLDTLQLDVADFATTIWQ\nQMEELGMAPALQPTQGAMPAFASAFQRRAGGVLVASHLQSFLEVSYRVLRHLAQP" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "15-80 hrs" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02249790" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00019" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00019/inserts/1706/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00019/inserts/2684/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00019> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Pegfilgrastim> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00019> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic3/neulasta.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Sargramostim> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P04141> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P04141> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:83869-56-1> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Sargramostim> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the treatment of cancer and bone marrow transplant" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Human, recombinant GM-CSF, expressed in yeast. Glycoprotein that is 127 residues. Substitution of Leu23 leads to a difference from native protein." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-19 16:45:59 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www.w3.org/2000/01/rdf-schema#label> "Sargramostim" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA451306" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "CSF2_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C639H1006N168O196S8" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "M13207" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "2GMF" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Sargramostim" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "14434.5" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Human granulocyte macrophage colony stimulating factor" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "20" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "5.05" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Sargramostim is used in the treatment of bone marrow transplant recipients or those exposed to chemotherapy an recovering from acut myelogenous leukemia, Leukine or GM-CSF is a hematopoietic growth factor which stimulates the survival, clonal expansion (proliferation) and differentiation of hematopoietic progenitor cells. GM-CSF is also capable of activating mature granulocytes and macrophages. After a bone marrow transplant or chemotherapy, patients have a reduced capacity to produce red and white blood cells. Supplementing them with external sources of GM-CSF helps bring the level of neutrophils back to normal so that they can better fight infections." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Sargramostim binds to the Granulocyte-macrophage colony stimulating factor receptor (GM-CSF-R-alpha or CSF2R) which stimulates a JAK2 STAT1/STAT3 signal transduction pathway. This leads to the production of hemopoietic cells and neutrophils" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00020 sequence\nAPARSPSPSTQPWEHVNAIQEALRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLE\nLYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFD\nCWEPVQE" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00020" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00020/inserts/1059/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00020/inserts/2070/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00020> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Sargramostim> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00020> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic/sargramostim.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Secretin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Secretin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For diagnosis of pancreatic exocrine dysfunction and gastrinoma" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "This drug is the synthetic form of natural secretin.  It is prepared using solid phase peptide synthesis.  Secretin is a peptide hormone produced in the S cells of the duodenum. Its main effect is to regulate the pH of the small  intestine\uFFFD\uFFFD\uFFFDs contents through the control of gastric acid secretion and buffering with bicarbonate. It was the first hormone to be discovered." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-19 16:46:13 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www.w3.org/2000/01/rdf-schema#label> "Secretin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA451315" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Solid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbHomologyId> "1GCN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C130H219N43O42" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Secretin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "3056.4" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "21" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.463" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "9.45" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Used in the diagnosis of pancreatic dysfunction or gastrinoma (stomach cancer), secretin is a hormone produced in the S cells of the duodenum in response to low local pH. It stimulates the secretion of bicarbonate from bicarbonate producing organs(liver, pancreas, Brunner's glands) when the pH drops below a set value. This helps neutralize the gastric acid entering the duodenum from the stomach. It also inhibits acid secretion from the stomach by reducing gastrin release from the G cells of the stomach." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Secretin binds to the secretin receptor found on the lining of S cells in the duodenum and G cells in the stomach. Binding leads to the secrection of bicarbonate or the reduction of the secretion of gastrin. Properly functioning organs (duodenum, pancreas and stomach) should be responsive to this hormone" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00021 sequence\nHSDGTFTSELSRLRDSARLQRLLQGLV" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "00874000" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00021" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00021/inserts/1668/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00021/inserts/2648/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00021> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Secretin> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00021> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic3/secretin.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Peginterferon_alfa-2b> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P01563> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P01563> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:99210-65-8> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Peginterferon_alfa-2b> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the treatment of chronic hepatitis C in patients not previously treated with interferon alpha who have compensated liver disease and are at least 18 years of age." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Peginterferon alfa-2b is a covalent conjugate of recombinant alfa-2b interferon with monomethoxy polyethylene glycol (PEG). The average molecular weight of the PEG portion of the molecule is 12,000 daltons. The average molecular weight of the PEG-Intron molecule is approximately 31,000 daltons. The specific activity of peginterferon alfa-2b is approximately 0.7 x 108 IU/mg protein. Interferon alfa-2b is a water-soluble protein with a molecular weight of 19,271 daltons produced by recombinant DNA techniques. It is obtained from the bacterial fermentation of a strain of <i>Escherichia coli</i> bearing a genetically engineered plasmid containing an interferon gene from human leukocytes. The PEG strand protects the molecule in vivo from proteolytic breakdown, substantially increases its in vivo half-life, and reduces immunogenicity by wrapping around and physically hindering access to the protein portion of the molecule." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-17 16:05:29 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www.w3.org/2000/01/rdf-schema#label> "Peginterferon alfa-2b" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA10153" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "IFNA2_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pdbExperimentalId> "1RH2" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Peginterferon alfa-2b" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "31000.0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/meltingPoint> "61 oC (Beldarrain, A. et al., Biochemistry 38:7865-7873 (1999)) Davis JM, Narachi MA, Levine HL, Alton NK, Arakawa T. Conformation and stability of two recombinant human interferon-alpha analogs." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/absorption> "Following a single subcutaneous dose of peginterferon alfa-2b, the mean absorption half-life (t&frac12; k<sub>a</sub>) was 4.6 hours." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "22" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "2004-03-01\t/drugs/22/fda_labels/621" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "5.99" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Interferon alpha also induce the synthesis of several key antiviral mediators, including 2'-5' oligoadenylate synthetase (2'-5' A synthetase) and protein kinase R." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which, upon dimerization, activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription)which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon alpha binds less stably to type I interferon receptors than interferon beta." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00022 sequence\nCDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMI\nQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVR\nKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "The mean elimination half-life is approximately 40 hours (range 22 to 60 hours) in patients with HCV infection." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02242966" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00022" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00022/inserts/1636/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00022/inserts/2622/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00022> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Peginterferon_alfa-2b> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00022> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic2/peginterferon.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Asparaginase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P37595> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P37595> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:9015-68-3> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Asparaginase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For treatment of acute lympocytic leukemia and non-Hodgkins lymphoma" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "L-asparagine amidohydrolase from E. coli" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2007-10-22 02:38:41 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www.w3.org/2000/01/rdf-schema#label> "Asparaginase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA448492" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "ASGX_ECOLI" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C1377H2208N382O442S17" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "U00096" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Asparaginase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "31731.9" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "E. coli L-asparagine amidohydrolase" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "23" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "2004-03-01\t/drugs/23/fda_labels/1110" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "0.059" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "4.67" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "In a significant number of patients with acute leukemia, the malignant cells are dependent on an exogenous source of asparagine for survival. Normal cells, however, are able to synthesize asparagine and thus are affected less by the rapid depletion produced by treatment with the enzyme asparaginase. Elspar exploits a metabolic defect in asparagine synthesis of some malignant cells." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Asparaginase converts asparagine to aspartic acid and ammonia. It facilitates production of oxaloacetate which is needed for general cellular metabolism. Some malignant cells lose the ability to produce asparagine and so the loss of exogenous sources of asparagine leads to cell death." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00023 sequence\nQMSLQQELRYIEALSAIVETGQKMLEAGESALDVVTEAVRLLEECPLFNAGIGAVFTRDE\nTHELDACVMDGNTLKAGAVAGVSHLRNPVLAARLVMEQSPHVMMIGEGAENFAFARGMER\nVSPEIFSTSLRYEQLLAARKEGATVLDHSGAPLDEKQKMGTVGAVALDLDGNLAAATSTG\nGMTNKLPGRVGDSPLVGAGCYANNASVAVSCTGTGEVFIRALAAYDIAALMDYGGLSLAE\nACERVVMEKLPALGGSGGLIAIDHEGNVALPFNTEGMYRAWGYAGDTPTTGIYREKGDTV\nATQ" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "8-30 hrs" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "01926438" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00023" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/contraindicationInsert> <http://129.128.185.122/drugbank2/drugs/DB00023/inserts/748/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00023/inserts/1773/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00023> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://xmlns.com/foaf/0.1/page> <http://en.wikipedia.org/wiki/Asparaginase> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00023> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic3/asparaginase.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P01225> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P01225> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/casRegistryNumber> <http://bio2rdf.org/cas:9002-71-5> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For detection of residueal or recurrent thyroid cancer" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Thyrotropin alfa is a heterodimeric glycoprotein comprised of two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites and a beta subunit of 118 residues containing one N-linked glycosylation site. The amino acid sequence of thyrotropin alfa is identical to that of human pituitary thyroid stimulating hormone." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2007-10-22 02:38:41 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www.w3.org/2000/01/rdf-schema#label> "Thyrotropin Alfa" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA451681" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "FSHB_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Liquid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C975H1513N267O304S26" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "M16647" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Thyrotropin Alfa" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "22672.9" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalIupacName> "Human alpha thyrotropin" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "24" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/fdaLabelFiles> "1998-11-01\t/drugs/24/fda_labels/742" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.330" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "7.50" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Binding of thyrotropin alfa to TSH receptors on normal thyroid epithelial cells or on well-differentiated thyroid cancer tissue stimulates iodine uptake and organification. Thyrogen is an exogenous source of human TSH that offers an additional diagnostic tool in the follow-up of patients with a history of well-differentiated thyroid cancer." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Thyrotropin Alfa binds to the thyrotropin receptors found on any residual thyroid cells or tissues. This stimulates radioactive iodine uptake for better radiodiagnostic imaging." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">Alpha chain\nAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCC\nVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS\n>Beta chain\nNSCELTNITIAIEKEECRFCISINTTWCAGYCYTRDLVYKDPARPKIQKTCTFKELVYET\nVRVPGCAHHADSLYTYPVATQCHCGKCDSDSTDCTVRGLGPSYCSFGEMKE" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "5 +/- 10 hrs" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02246016" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00024" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/vocab/resource/class/Offer> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/drugs> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/interactionInsert> <http://129.128.185.122/drugbank2/drugs/DB00024/inserts/2311/full> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://xmlns.com/foaf/0.1/page> <http://www.drugbank.ca/drugs/DB00024> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00024> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/rxlistLink> <http://www.rxlist.com/cgi/generic2/thyrotropin.htm> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://xmlns.com/foaf/0.1/page> <http://dbpedia.org/page/Antihemophilic_Factor> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotPage> <http://www.uniprot.org/uniprot/P00451> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotId> <http://bio2rdf.org/uniprot:P00451> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Antihemophilic_Factor> .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/creationDate> "2005-06-13 13:24:05 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/indication> "For the treatment of hemophilia A, von Willebrand diseae and Factor XIII deficiency" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/description> "Human recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/updateDate> "2008-03-19 16:32:40 UTC" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www.w3.org/2000/01/rdf-schema#label> "Antihemophilic Factor" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmgkbId> "PA448445" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/massSpecFile> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/swissprotName> "FA8_HUMAN" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/structure> "0" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/state> "Solid" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalFormula> "C11794H18314N3220O3553S83" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genbankId> "M14113" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/genericName> "Antihemophilic Factor" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/molecularWeightAverage> "264725.5" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/limsDrugId> "25" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/experimentalLogpHydrophobicity> "-0.533" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pkaIsoelectricPoint> "6.97" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/pharmacology> "Antihemophilic Factor binds factor IXa along with calcium and phospholipid, This complex converts factor X to factor Xa to facilitate clotting cascade." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/mechanismOfAction> "Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia)." .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/chemicalStructure> ">DB00025 sequence\nATRRYYLGAVELSWDYMQSDLGELPVDARFPPRVPKSFPFNTSVVYKKTLFVEFTDHLFN\nIAKPRPPWMGLLGPTIQAEVYDTVVITLKNMASHPVSLHAVGVSYWKASEGAEYDDQTSQ\nREKEDDKVFPGGSHTYVWQVLKENGPMASDPLCLTYSYLSHVDLVKDLNSGLIGALLVCR\nEGSLAKEKTQTLHKFILLFAVFDEGKSWHSETKNSLMQDRDAASARAWPKMHTVNGYVNR\nSLPGLIGCHRKSVYWHVIGMGTTPEVHSIFLEGHTFLVRNHRQASLEISPITFLTAQTLL\nMDLGQFLLFCHISSHQHDGMEAYVKVDSCPEEPQLRMKNNEEAEDYDDDLTDSEMDVVRF\nDDDNSPSFIQIRSVAKKHPKTWVHYIAAEEEDWDYAPLVLAPDDRSYKSQYLNNGPQRIG\nRKYKKVRFMAYTDETFKTREAIQHESGILGPLLYGEVGDTLLIIFKNQASRPYNIYPHGI\nTDVRPLYSRRLPKGVKHLKDFPILPGEIFKYKWTVTVEDGPTKSDPRCLTRYYSSFVNME\nRDLASGLIGPLLICYKESVDQRGNQIMSDKRNVILFSVFDENRSWYLTENIQRFLPNPAG\nVQLEDPEFQASNIMHSINGYVFDSLQLSVCLHEVAYWYILSIGAQTDFLSVFFSGYTFKH\nKMVYEDTLTLFPFSGETVFMSMENPGLWILGCHNSDFRNRGMTALLKVSSCDKNTGDYYE\nDSYEDISAYLLSKNNAIEPRSFSQNSRHPSTRQKQFNATTIPENDIEKTDPWFAHRTPMP\nKIQNVSSSDLLMLLRQSPTPHGLSLSDLQEAKYETFSDDPSPGAIDSNNSLSEMTHFRPQ\nLHHSGDMVFTPESGLQLRLNEKLGTTAATELKKLDFKVSSTSNNLISTIPSDNLAAGTDN\nTSSLGPPSMPVHYDSQLDTTLFGKKSSPLTESGGPLSLSEENNDSKLLESGLMNSQESSW\nGKNVSSTESGRLFKGKRAHGPALLTKDNALFKVSISLLKTNKTSNNSATNRKTHIDGPSL\nLIENSPSVWQNILESDTEFKKVTPLIHDRMLMDKNATALRLNHMSNKTTSSKNMEMVQQK\nKEGPIPPDAQNPDMSFFKMLFLPESARWIQRTHGKNSLNSGQGPSPKQLVSLGPEKSVEG\nQNFLSEKNKVVVGKGEFTKDVGLKEMVFPSSRNLFLTNLDNLHENNTHNQEKKIQEEIEK\nKETLIQENVVLPQIHTVTGTKNFMKNLFLLSTRQNVEGSYDGAYAPVLQDFRSLNDSTNR\nTKKHTAHFSKKGEEENLEGLGNQTKQIVEKYACTTRISPNTSQQNFVTQRSKRALKQFRL\nPLEETELEKRIIVDDTSTQWSKNMKHLTPSTLTQIDYNEKEKGAITQSPLSDCLTRSHSI\nPQANRSPLPIAKVSSFPSIRPIYLTRVLFQDNSSHLPAASYRKKDSGVQESSHFLQGAKK\nNNLSLAILTLEMTGDQREVGSLGTSATNSVTYKKVENTVLPKPDLPKTSGKVELLPKVHI\nYQKDLFPTETSNGSPGHLDLVEGSLLQGTEGAIKWNEANRPGKVPFLRVATESSAKTPSK\nLLDPLAWDNHYGTQIPKEEWKSQEKSPEKTAFKKKDTILSLNACESNHAIAAINEGQNKP\nEIEVTWAKQGRTERLCSQNPPVLKRHQREITRTTLQSDQEEIDYDDTISVEMKKEDFDIY\nDEDENQSPRSFQKKTRHYFIAAVERLWDYGMSSSPHVLRNRAQSGSVPQFKKVVFQEFTD\nGSFTQPLYRGELNEHLGLLGPYIRAEVEDNIMVTFRNQASRPYSFYSSLISYEEDQRQGA\nEPRKNFVKPNETKTYFWKVQHHMAPTKDEFDCKAWAYFSDVDLEKDVHSGLIGPLLVCHT\nNTLNPAHGRQVTVQEFALFFTIFDETKSWYFTENMERNCRAPCNIQMEDPTFKENYRFHA\nINGYIMDTLPGLVMAQDQRIRWYLLSMGSNENIHSIHFSGHVFTVRKKEEYKMALYNLYP\nGVFETVEMLPSKAGIWRVECLIGEHLHAGMSTLFLVYSNKCQTPLGMASGHIRDFQITAS\nGQYGQWAPKLARLHYSGSINAWSTKEPFSWIKVDLLAPMIIHGIKTQGARQKFSSLYISQ\nFIIMYSLDGKKWQTYRGNSTGTLMVFFGNVDSSGIKHNIFNPPIIARYIRLHPTHYSIRS\nTLRMELMGCDLNSCSMPLGMESKAISDAQITASSYFTNMFATWSPSKARLHLQGRSNAWR\nPQVNNPKEWLQVDFQKTMKVTGVTTQGVKSLLTSMYVKEFLISSSQDGHQWTLFFQNGKV\nKVFQGNQDSFTPVVNSLDPPLLTRYLRIHPQSWVHQIALRMEVLGCEAQDLY" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/halfLife> "8.4-19.3 hrs" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/dpdDrugIdNumber> "02242491" .
<http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00025> <http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugbank/primaryAccessionNo> "DB00025" .